0

Global Huntington's Disease Therapeutics Market 2017-2021

  • Published: Aug 2017
  • Pages: 86
  • SKU: IRTNTR14144
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This industry research report identifies F. Hoffmann-La Roche, H. Lundbeck, Prana Biotechnology, and Teva Pharmaceutical Industries as the key vendors in the global Huntington’s disease therapeutics market. This industry research report also presents a competitive analysis of the market by drug class (Antidopaminergics, Anticonvulsants, Antipsychotics, and Antidepressants) and by geography (the Americas, APAC, and EMEA).

Overview of the global Huntington’s disease therapeutics market

Technavio’s market research analysis identifies the early onset of disease symptoms that increases the demand for Huntington’s disease (HD) therapeutics as one of the primary growth factors for the Huntington’s disease therapeutics market. HD is equally prevalent in both males and females and affects people irrespective of their ethnicity. The disease symptoms may appear anytime in the individual’s life and the etiology is genetic. The person who inherits the mutated genes from their affected parents will probably suffer from the disease sometime in their lifetime. According to our market research analysts, this market will grow steadily at a CAGR of around 15% by 2021.

The advancements in science and the introduction of nanotechnologies has resulted in modern techniques such as bioinformatics, molecular targeting, nanotechnology, and personalized medicines that has facilitated drug development to cure neurodegenerative disorders. The advancements have resulted in the better understanding of the pathogenesis of disease at genetic and molecular level that further results in the discovery of new targets for therapy and disease modifying drugs. Intensive R&D has resulted in the identification of an enzyme that can potentially reverse the progression of HD. This research analysis identifies the advancements in biomedical sciences as one of the key trends behind the growth of the Huntington’s disease therapeutics market.

Competitive landscape and key vendors

The Huntington’s disease therapeutics market is fragmented due to the presence of several large and small vendors who are focusing on consolidating their market shares through strategic alliances and acquisitions. Government support in terms of granting orphan drug designation, major patent expiries, and the rising awareness about HD, are major factors that play a significant role in the performance of the vendors in this marketspace.

The leading vendors in the market are -

  • F. Hoffmann-La Roche
  • H. Lundbeck
  • Prana Biotechnology
  • Teva Pharmaceutical Industries

The other prominent vendors in the market are Intellect Neurosciences, Horizon Pharma, Sangamo Therapeutics, and Vertex Pharmaceuticals.

Segmentation by drug class and analysis of the Huntington’s disease therapeutics market

Owing to their effect on reversible depletion of monoamines including dopamine, Antidopaminergics agents are primarily suitable to treat chorea, which is the most common problem associated with HD. Tetrabenazine (TBZ) is primarily used for pharmacological and the symptomatic treatment of chorea associated with HD due to their therapeutic efficacy.

Geographical segmentation and analysis of Huntington’s disease therapeutics market

  • Americas
  • APAC
  • EMEA

The Americas is witnessing increasing incidences of HD. The availability of increased patient pool and the rise in government initiatives boost the research and development of novel therapeutics for the treatment of HD. The rising investments towards the launch of new drugs for the treatment of chorea will positively influence the growth of the Huntington’s disease therapeutics market in this region.

Key questions answered in the report include

  • What will the huntington’s disease therapeutics market size and growth rate be in 2021?
  • What are the key factors driving the global Huntington’s disease therapeutics market?
  • What are the key market trends impacting the growth of the global Huntington’s disease therapeutics market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global Huntington’s disease therapeutics market?
  • What are the market opportunities and threats faced by the vendors in the global Huntington’s disease therapeutics market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global Huntington’s disease therapeutics market?

Technavio also offers customization on reports based on specific client requirement

 

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: HD: An introduction

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Pipeline

PART 08: Market segmentation  by drug-class

  • Market scenario by drug-class
  • Antidopaminergics
  • Anticonvulsants
  • Antipsychotics
  • Antidepressants
  • Others

PART 09: Geographical segmentation

  • Market segmentation by geography
  • HD therapeutics market in Americas
  • HD therapeutics market in EMEA
  • HD therapeutics market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Market challenges

PART 12: Market trends

  • Advances in biomedical sciences
  • Focus on regenerative therapies for mental disorders
  • Rising public interest toward mental health

PART 13: Vendor landscape

  • Competitive scenario

PART 14: Key vendor analysis

  • F. Hoffmann-La Roche
  • H. Lundbeck
  • Prana Biotechnology
  • Teva Pharmaceutical Industries
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>